Figure 3.
H19 sponged miR-106b-5p in BMVECs
(a) Bioinformatic analysis predicted the binding sites between miR-106b-5p and H19. (b) Dual-luciferase reporter assays confirmed that miR-106b-5p was a target of H19 in BMVECs. (c) Interactions between miR-106b-5p and H19 were determined using RNA pull-down assays. *P < 0.05 (d) The expression of miR-106b-5p was determined by RT-qPCR. (E) miR-106b-5p expression levels in BMVECs treated with or without OGD/H. *P < 0.05, **P < 0.01, ##P < 0.01.